Medicare Rx Outlook Hinges On Scope Of "Reform," Hill Staffers Say

The outlook for Medicare prescription drug legislation in the 107th Congress depends on the scope of "Medicare reform" proposals that are attached to the bill, House Ways & Means/Health Subcommittee minority staff member Cybele Bjorkland told the Schwab Washington Research Group healthcare conference May 7 in Washington, D.C.